Kelgan Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 39.12%
- Profit Growth 24.08%
- Ebitda 11.44%
- Net Worth 22.08%
- Total Assets -6.71%
About Kelgan Pharmaceutical
Kelgan Pharmaceutical Private Limited (KPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 November 2016 (Eight years and three months 7 days old ). Its registered office is in Kota, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kewal Sharma and Lokesh Gautam serve as directors at the Company.
Company Details
-
Location
Kota, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U33309RJ2016PTC056331
-
Company No.
056331
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Nov 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Kelgan Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kewal Sharma
|
Director | 07-Nov-2016 | Current |
|
Lokesh Gautam
|
Director | 07-Nov-2016 | Current |
Financial Performance of Kelgan Pharmaceutical.
Kelgan Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 39.12% increase. The company also saw a substantial improvement in profitability, with a 24.08% increase in profit. The company's net worth Soared by an impressive increase of 22.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kelgan Pharmaceutical?
Unlock access to Kelgan Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kelgan Pharmaceutical?
Unlock and access historical data on people associated with Kelgan Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kelgan Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kelgan Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.